M&A

Innoviva Entered into a Definitive Merger Agreement with Entasis Therapeutics

Innoviva Entered into a Definitive Merger Agreement with Entasis Therapeutics

Shots: Innoviva to purchase all the remaining equity securities of Entasis for $2....

Cortexyme Entered into an Agreement to Acquire Novosteo for the Treatment of Rare Skeletal Diseases

Cortexyme Entered into an Agreement to Acquire Novosteo for the Treatment of Rare Skeletal Diseases

Shots: Following the completion of the acquisition, Novosteo stockholders will own...

Pfizer to Acquire Biohaven for ~$11.6B

Pfizer to Acquire Biohaven for ~$11.6B

Shots: Pfizer to acquire all outstanding shares of Biohaven for $148.50/share in c...

Image